BlueSphere Bio CSO Alan Korman Recipient of Esteemed 2025 William B. Coley Award
Alan Korman honored in the category of tumor immunology for foundational role in checkpoint inhibitors PITTSBURGH, July 29, 2025 /PRNewswire/ — BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced its Chief Scientific Officer, Alan Korman, Ph.D. is the 2025 recipient of one of the Cancer Research […]
BlueSphere Bio CSO Alan Korman Recipient of Esteemed 2025 William B. Coley Award Read Post »
Press







